Danny N Khalil

Danny N Khalil

UNVERIFIED PROFILE

Are you Danny N Khalil?   Register this Author

Register author
Danny N Khalil

Danny N Khalil

Publications by authors named "Danny N Khalil"

Are you Danny N Khalil?   Register this Author

15Publications

639Reads

32Profile Views

Immune checkpoint inhibitors for hepatocellular carcinoma.

Cancer 2019 Oct 10;125(19):3312-3319. Epub 2019 Jul 10.

Gastrointestinal Oncology Service, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.32076DOI Listing
October 2019

Biomarkers: What Role Do They Play (If Any) for Diagnosis, Prognosis and Tumor Response Prediction for Hepatocellular Carcinoma?

Dig Dis Sci 2019 04;64(4):918-927

Gastrointestinal Oncology Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, 300 East 66th Street, New York, NY, 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s10620-019-05517-6DOI Listing
April 2019

Targeted APC Activation in Cancer Immunotherapy to Enhance the Abscopal Effect.

Front Immunol 2019 2;10:604. Epub 2019 Apr 2.

Swim Across America and Ludwig Collaborative Laboratory, Immunology Program, Parker Institute for Cancer Immunotherapy, Memorial Sloan Kettering Cancer Center, New York, NY, United States.

View Article

Download full-text PDF

Source
https://www.frontiersin.org/article/10.3389/fimmu.2019.00604
Publisher Site
http://dx.doi.org/10.3389/fimmu.2019.00604DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6454083PMC
April 2019

Classification of Pancreatic Cancer: Ready for Practical Application?

Clin Cancer Res 2018 09 11;24(18):4355-4356. Epub 2018 May 11.

Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-18-1113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6139048PMC
September 2018

The future of cancer treatment: immunomodulation, CARs and combination immunotherapy.

Nat Rev Clin Oncol 2016 May 15;13(5):273-90. Epub 2016 Mar 15.

Department of Medicine, Memorial Sloan Kettering Cancer Center, 1275 York Avenue, New York, New York 10065, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrclinonc.2016.25DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5551685PMC
May 2016

The New Era of Cancer Immunotherapy: Manipulating T-Cell Activity to Overcome Malignancy.

Adv Cancer Res 2015 9;128:1-68. Epub 2015 Jun 9.

Ludwig Collaborative and Swim Across America Laboratory, Memorial Sloan Kettering Cancer Center, New York, USA; Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/bs.acr.2015.04.010DOI Listing
April 2016

Modern Immunotherapy for the Treatment of Advanced Gastrointestinal Cancers.

Oncology (Williston Park) 2016 Jan;30(1):85-90, 93

View Article

Download full-text PDF

Source
January 2016

Treatments for noncutaneous melanoma.

Hematol Oncol Clin North Am 2014 Jun;28(3):507-21

Developmental Therapeutics, Department of Medicine, Memorial Sloan-Kettering Cancer Center, 300 East 66th Street, No. 1071, New York, NY 10065, USA. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.hoc.2014.02.006DOI Listing
June 2014

Why does Oncotype DX recurrence score reduce adjuvant chemotherapy use?

Breast Cancer Res Treat 2012 Aug 22;134(3):1125-32. Epub 2012 Jun 22.

Winthrop-University Hospital Campus of SUNY Health Sciences Center at Stony Brook, 200 Old Country Rd, Room #450, Mineola, NY 11501, USA.

View Article

Download full-text PDF

Source
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4349488PMC
http://dx.doi.org/10.1007/s10549-012-2134-1DOI Listing
August 2012